Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma
Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma have?
Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma has 690 citations in the OpenAlex counts ScholarIQ stores.
When was Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma published?
Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma has 2008 year in the ScholarIQ index.
What is the open-access status of Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma?
Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma has closed oa status in the ScholarIQ index.
What is the DOI of Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma?
The DOI for Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma is on the source record.
What is the PMID of Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma?
The PMID for Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma is on the source record.
What is the OpenAlex record for Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma?
The OpenAlex for Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma is on the source record.